Recent articles from Anastasiia
7 Biotechs Fighting Rare Diseases With Gene-Editing Tech
Rare diseases sit at an uncomfortable scale: about 30 million people in the U.S., roughly >300 million worldwide. According to NIH, there are an estimated 6,000 to 8,000 rare diseases, though the exact number is continually changing as new …
New AI Reportedly Surpasses AlphaFold 3 in Drug-Protein Binding Prediction
Genesis Molecular AI, in collaboration with NVIDIA, has announced a generative 3D foundation model for protein–ligand structure prediction, Pearl (Placing Every Atom in the Right Location). Genesis reports state-of-the-art results on public benchmarks …
7 Notable Companies Advancing Women’s Health with AI
Back in 2016, Ida Tin, the CEO behind the renowned period-tracking app Clue, introduced the term "FemTech" to capture the wave of startups pushing the boundaries of technology in the realm of female health. Today, the term encompasses an even …
15 Useful Mobile Apps For Life Scientists
Nowadays, mobile devices are ubiquitous with an estimated number of smartphones and tablet PCs to exceed two billion globally.
The availability of internet connection in most public places, powerful processors, and user-friendly touch screen technologies make mobile devices useful not …
5 AI-Powered Companies Transforming the Future of Fertility Care
The field of fertility treatments is experiencing a surge in demand, fueled by several significant factors. A shift towards starting families at a later age, the increasing number of same-sex couples seeking assistance, and concerning studies revealing a decline in …
BigHat Introduces AI Platform for Antibody Design and Optimization
BigHat Biosciences, headquartered in San Mateo, California, has unveiled the Reccy Antibody Design Studio (RADS), a fully integrated platform combining machine learning with high-throughput experimental validation for antibody development. The system is designed to accelerate the discovery and …
DARPA Funds PolarisQB to Advance Quantum-Aided Drug Design
The U.S. Defense Advanced Research Projects Agency (DARPA) has awarded Polaris Quantum Biotech (PolarisQB) an Embedded Entrepreneurship Initiative (EEI) grant to accelerate commercialization of its quantum computing platform for drug design. The funding follows earlier DARPA-backed research under the “Imagining …
BenchSci and Thermo Fisher Collaborate to Develop AI Tools for Preclinical R&D
Toronto-based BenchSci has entered a strategic partnership with Thermo Fisher Scientific to create AI-powered tools aimed at improving experimental design, reagent selection, and overall R&D productivity. The collaboration combines BenchSci’s ASCEND AI platform with US-based Thermo Fisher’s laboratory instruments, consumables, …
AI Framework Produces Functional Nanobodies with Reduced Screening
A new preprint from the Brian Hie and Xiaojing Gao labs, in collaboration with the Arc Institute, introduces Germinal, a generative AI framework designed to accelerate antibody creation. Applied to nanobodies, it reduces the need for large-scale laboratory screening by …
Aera Reports Preclinical Data on Lipid Nanoparticle-Delivered In Vivo CAR-T Therapy
Aera Therapeutics has presented preclinical results and nominated AERA-109, its first development candidate, for B cell–mediated autoimmune diseases. The candidate is built on the company’s targeted lipid nanoparticle (tLNP) delivery platform and is designed to generate CAR-T cells directly inside …